TIAA CREF Investment Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $145K | Hold |
4,410
| – | – | ﹤0.01% | 2922 |
|
|
2018
Q4 | $262K | Hold |
4,410
| – | – | ﹤0.01% | 2809 |
|
|
2018
Q3 | $619K | Buy |
4,410
+1,492
| +51% | +$209K | ﹤0.01% | 2628 |
|
|
2018
Q2 | $358K | Buy |
+2,918
| New | +$358K | ﹤0.01% | 2902 |
|
|
2017
Q4 | – | Sell |
-4,601
| Closed | -$194K | – | 3070 |
|
|
2017
Q3 | $194K | Hold |
4,601
| – | – | ﹤0.01% | 3047 |
|
|
2017
Q2 | $194K | Sell |
4,601
-9,552
| -67% | -$403K | ﹤0.01% | 3090 |
|
|
2017
Q1 | $791K | Buy |
14,153
+4,109
| +41% | +$230K | ﹤0.01% | 2627 |
|
|
2016
Q4 | $383K | Sell |
10,044
-1,749
| -15% | -$66.7K | ﹤0.01% | 2922 |
|
|
2016
Q3 | $468 | Sell |
11,793
-1,935
| -14% | -$77 | ﹤0.01% | 2874 |
|
|
2016
Q2 | $987K | Buy |
13,728
+3,942
| +40% | +$283K | ﹤0.01% | 2513 |
|
|
2016
Q1 | $784K | Buy |
9,786
+4,613
| +89% | +$370K | ﹤0.01% | 2607 |
|
|
2015
Q4 | $390K | Hold |
5,173
| – | – | ﹤0.01% | 2960 |
|
|
2015
Q3 | $1.98M | Sell |
5,173
-183
| -3% | -$70.2K | ﹤0.01% | 2145 |
|
|
2015
Q2 | $2.23M | Buy |
5,356
+2,271
| +74% | +$944K | ﹤0.01% | 2235 |
|
|
2015
Q1 | $1.47M | Buy |
3,085
+451
| +17% | +$214K | ﹤0.01% | 2416 |
|
|
2014
Q4 | $975K | Buy |
2,634
+1,388
| +111% | +$514K | ﹤0.01% | 2668 |
|
|
2014
Q3 | $294K | Buy |
+1,246
| New | +$294K | ﹤0.01% | 3061 |
|